Your browser doesn't support javascript.
loading
Effects of Orally Delivered Alpha-Galactosidase A on Gastrointestinal Symptoms in Patients With Fabry Disease.
Lenders, Malte; Boutin, Michel; Auray-Blais, Christiane; Brand, Eva.
Afiliação
  • Lenders M; Department of Internal Medicine D, and Interdisciplinary Fabry Center (IFAZ), University Hospital Muenster, Muenster, Germany.
  • Boutin M; Department of Pediatrics, Division of Medical Genetics, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
  • Auray-Blais C; Department of Pediatrics, Division of Medical Genetics, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
  • Brand E; Department of Internal Medicine D, and Interdisciplinary Fabry Center (IFAZ), University Hospital Muenster, Muenster, Germany. Electronic address: Eva.Brand@ukmuenster.de.
Gastroenterology ; 159(4): 1602-1604, 2020 10.
Article em En | MEDLINE | ID: mdl-32534932

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Fabry / Alfa-Galactosidase / Gastroenteropatias Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Fabry / Alfa-Galactosidase / Gastroenteropatias Idioma: En Ano de publicação: 2020 Tipo de documento: Article